<SEC-DOCUMENT>0001209191-18-063964-index.html : 20181221 <SEC-HEADER>0001209191-18-063964.hdr.sgml : 20181221 <ACCEPTANCE-DATETIME>20181221171635 ACCESSION NUMBER: 0001209191-18-063964 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181220 FILED AS OF DATE: 20181221 DATE AS OF CHANGE: 20181221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 181250495 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vertex Pharmaceuticals (Europe) Ltd CENTRAL INDEX KEY: 0001761216 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 181250496 BUSINESS ADDRESS: STREET 1: 2 KINGDOM STREET, 9TH FLOOR CITY: LONDON STATE: X0 ZIP: W2 6BD BUSINESS PHONE: 617-341-6100 MAIL ADDRESS: STREET 1: 2 KINGDOM STREET, 9TH FLOOR CITY: LONDON STATE: X0 ZIP: W2 6BD ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 </SEC-HEADER> <DOCUMENT> <TYPE>3 <SEQUENCE>1 <FILENAME>doc3.xml <DESCRIPTION>FORM 3 SUBMISSION <TEXT> Document 1 - file: doc3.html
Document 1 - RAW XML: doc3.xml
</DOCUMENT> </SEC-DOCUMENT>